Search
for
Sort by
Research
30-60 / 1000+ results
research Case Report: Arteriovenous Fistula
The document's conclusion cannot be provided because the document is not available for parsing.
research Finasteride/testosterone
research SIMULTANEOUS DETERMINATION OF FINASTERIDE AND TAMSULOSIN IN COMBINED DOSAGE FORM BY USING RP-HPLC METHOD
Method accurately measures finasteride and tamsulosin in combined drug form.
research BindingDB Entry 50021519: Discovery of (2S)-N-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment.
research Advertiser Beware
The document's conclusion cannot be provided because the document is not readable or understandable.
research Solubilization and Solid‐State Characterization of a Poorly Soluble 5‐α Reductase Inhibitor
GI197111X is best dissolved in Capmul MCM for trials.
research Treating patients with female alopecia
The document's conclusion cannot be provided because the document is not available or cannot be parsed.
research RP-HPLC-Based Stability-Indicating Analytical Method for Concurrent Determination of Finasteride and Tadalafil: Development and Validation
A reliable method was developed to measure Finasteride and Tadalafil together, showing they degrade under certain conditions.
research Tissue Laxity Based on Donor Tissue Ballooning
The document's conclusion cannot be provided because the document is not readable or understandable.
research 198 Dutasteride for men with androgenic alopecia unresponsive to finasteride
research Mutation in 5′ upstream region of GCH I gene causes familial dopa-responsive dystonia
A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.
research “Finasteride”
research Kin‐cohort analysis of LRRK2‐G2019S penetrance in Parkinson's disease
The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.
research Hair Transplantation
The document's conclusion cannot be provided because the content is not accessible.
research Message from the Program Chair of the 2007 Annual Scientific Meeting
The document's content couldn't be processed.
research 396 A novel investigator global assessment score for the evaluation of keratosis pilaris
The document's conclusion cannot be provided because the content is not accessible.
research Erratum
The document contains an error.
research To megasession or not to megasession: That seems to be the question
The document's conclusion cannot be provided because the content is not available.
research Report of Japanese Meeting, Tokyo, June 27, 1998
The document's content cannot be summarized because it is not accessible or understandable.
research Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer
TGM3 is important for skin and hair structure and may help diagnose cancer.
research BC05 Technological and clinical demonstration of a skin ageing analysis prototype
The prototype for analyzing skin aging works technically and clinically.
research Frontal hairline design
The document's conclusion cannot be provided because the content is not accessible.
research 96 Hair Restoration
The document cannot be summarized as it is not provided or is unclear.
research Malignant Melanoma
The document's conclusion cannot be provided because the document is not readable or understandable.
research IMPROVING THE MANAGEMENT SYSTEM OF HOLDING COMPANIES AND FINANCIAL-INDUSTRIAL GROUPS IN AZERBAIJAN
The document's conclusion cannot be provided as the content is not available for parsing.
research TBG096 stimulates hair regeneration through IGF-1R-mediated angiogenesis
research Doctor’s (patient’s) guide to estimating transplant grafts
The document could not be processed to provide a conclusion.
research Live Workshop 1996
The document cannot be understood or processed.
research Combined C3b and Factor B Autoantibodies and MPGN Type II
The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.